PMC10251290_01
Androgenetic alopecia in premenopausal women. Baseline control (a) and after 3 months (b) of monthly treatment with 1 ml 0.5% bicalutamide mesotherapy
IJT-15-39-g001.jpg
PMC10251290_01_IJT-15-39-g001.jpg
F1
The degree of alopecia was not modified in any of the cases; however, in all cases, a subtle improvement in hair density was described after the third session [Figure 1a and b], which did not persist at the 6-month visit.